Vathany Kulasingam, PhD

Clinician Investigator, Princess Margaret Cancer Centre
Cancer Clinical Research Unit (CCRU), Princess Margaret Cancer Centre
https://orcid.org/0000-0001-5610-873X
Keywords: proteomics, mass spectrometry, ovarian cancer, metabolomics

Dr. Kulasingam's laboratory is focusing on using high-throughput “omics” technologies to understand disease pathogenesis, with a particular emphasis on cancer and rheumatic diseases and its application to clinical practice.

 
Defining appropriate utilization of AST testing.
Clin Biochem. 2020 Feb 12;:
Mohammed-Ali Z, Brinc D, Kulasingam V, Selvaratnam R
Evaluation of a coated blade spray-tandem mass spectrometry assay as a new tool for the determination of immunosuppressive drugs in whole blood.
Anal Bioanal Chem. 2020 Jan 06;:
Rickert DA, Gómez-Ríos GA, Nazdrajić E, Tascon M, Kulasingam V, Pawliszyn JB
Emerging role of clinical mass spectrometry in pathology.
J Clin Pathol. 2019 Nov 05;:
Fung AWS, Sugumar V, Ren AH, Kulasingam V
A Puzzling Case of Hyperviscosity Syndrome.
J Appl Lab Med. 2019 Oct 29;:
Taher J, Chen C, Kulasingam V
What Is Really in This Weight Loss Supplement?
J Appl Lab Med. 2019 09;4(2):270-273
Parker ML, Stefan C, Reich HN, Kulasingam V
Unraveling endometriosis-associated ovarian carcinomas using integrative proteomics.
F1000Res. 2018;7:189
Leung F, Bernardini MQ, Liang K, Batruch I, Rouzbahman M, Diamandis EP, Kulasingam V
Towards personalized tumor markers.
NPJ Precis Oncol. 2017;1(1):17
Kulasingam V, Prassas I, Diamandis EP
Evaluation of electrochemiluminescence immunoassays for immunosuppressive drugs on the Roche cobas e411 analyzer.
F1000Res. 2017;6:1832
Fung AWS, Knauer MJ, Blasutig IM, Colantonio DA, Kulasingam V
A patient with monoclonal gammopathy-related nephrotic syndrome revealed no electrophoretic "nephrotic pattern" or skewed free light chain ratio.
Clin Biochem. 2018 Jan;51:110-111
Truong D, Blasutig IM, Kulasingam V, Chan PC
Urinary adenosine excretion in type 1 diabetes.
Am J Physiol Renal Physiol. 2017 Aug 01;313(2):F184-F191
Rajasekeran H, Lytvyn Y, Bozovic A, Lovshin JA, Diamandis E, Cattran D, Husain M, Perkins BA, Advani A, Reich HN, Kulasingam V, Cherney DZI

Pages

Clinician Investigator, Princess Margaret Cancer Centre
Cancer Clinical Research Unit (CCRU), Princess Margaret Cancer Centre

Deputy Head, Clinical Biochemistry, University Health Network
Associate Professor, Laboratory Medicine & Pathobiology, University of Toronto